» Articles » PMID: 19277247

The Minnesota Grading System Using Fundus Autofluorescence of Eye Bank Eyes: a Correlation to Age-related Macular Degeneration (an AOS Thesis)

Overview
Specialty Ophthalmology
Date 2009 Mar 12
PMID 19277247
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To establish a grading system of eye bank eyes using fundus autofluorescence (FAF) and identify a methodology that correlates FAF to age-related macular degeneration (AMD) with clinical correlation to the Age-Related Eye Disease Study (AREDS).

Methods: Two hundred sixty-two eye bank eyes were evaluated using a standardized analysis of FAF. Measurements were taken with the confocal scanning laser ophthalmoscope (cSLO). First, high-resolution, digital, stereoscopic, color images were obtained and graded according to AREDS criteria. With the neurosensory retina removed, mean FAF values were obtained from cSLO images using software analysis that excludes areas of atrophy and other artifact, generating an FAF value from a grading template. Age and AMD grade were compared to FAF values. An internal fluorescence reference standard was tested.

Results: Standardization of the cSLO machine demonstrated that reliable data could be acquired after a 1-hour warm-up. Images obtained prior to 1 hour had falsely elevated levels of FAF. In this initial analysis, there was no statistical correlation of age to mean FAF. There was a statistically significant decrease in FAF from AREDS grade 1, 2 to 3, 4 (P < .0001). An internal fluorescent standard may serve as a quantitative reference.

Conclusions: The Minnesota Grading System (MGS) of FAF (MGS-FAF) establishes a standardized methodology for grading eye bank tissue to quantify FAF compounds in the retinal pigment epithelium and correlate these findings to the AREDS. Future studies could then correlate specific FAF to the aging process, histopathology AMD phenotypes, and other maculopathies, as well as to analyze the biochemistry of autofluorescent fluorophores.

Citing Articles

Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19.

Jidigam V, Singh R, Batoki J, Milliner C, Sawant O, Bonilha V Graefes Arch Clin Exp Ophthalmol. 2021; 260(4):1275-1288.

PMID: 34714382 PMC: 8553591. DOI: 10.1007/s00417-021-05460-1.


Enhanced Detection of Sub-Retinal Pigment Epithelial Cell Layer Deposits in Human and Murine Tissue: Imaging Zinc as a Biomarker for Age-Related Macular Degeneration (An American Ophthalmological Society Thesis).

van Kuijk F, McPherson S, Roehrich H Trans Am Ophthalmol Soc. 2017; 115:T3.

PMID: 29021717 PMC: 5598790.

References
1.
Klaver C, Wolfs R, Vingerling J, Hofman A, de Jong P . Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998; 116(5):653-8. DOI: 10.1001/archopht.116.5.653. View

2.
Holz F, Bellmann C, Margaritidis M, Schutt F, Otto T, Volcker H . Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999; 237(2):145-52. DOI: 10.1007/s004170050209. View

3.
Buch H, Vinding T, La Cour M, Appleyard M, Jensen G, Nielsen N . Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004; 111(1):53-61. DOI: 10.1016/j.ophtha.2003.05.010. View

4.
Boulton M, Marshall J . Effects of increasing numbers of phagocytic inclusions on human retinal pigment epithelial cells in culture: a model for aging. Br J Ophthalmol. 1986; 70(11):808-15. PMC: 1040833. DOI: 10.1136/bjo.70.11.808. View

5.
. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119(10):1417-36. PMC: 1462955. DOI: 10.1001/archopht.119.10.1417. View